Clinical research networks continue to play a pivotal role in supporting pipeline development.  However, the importance of these networks extends well beyond the conduct of clinical trials.  Clinical investigators can support market conditioning, serve as important levers for informing evidence-based clinical pathways/guidelines, and aid in the generation of real-world evidence – all of which are critical to promoting market access and product adoption.

 In this dynamic environment, pharmaceutical companies need research networks they can access quickly to address strategic questions across the product lifecycle. Unfortunately, market dynamics, including shifts in research focus, greater competition, and more restricted access have limited the effectiveness of more traditional approaches to establishing these networks.  Moving forward, how companies develop these networks needs to fundamentally change, reflecting the reality of today’s marketplace. 

Read More

Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.

Privacy is important. We do not share registrant information with anyone outside of Numerof & Associates. For details, please see our Privacy Policy. Subscribers to our mailings can unsubscribe instantly at any time.

×